Tivity Health (TVTY) Upgraded at Zacks Investment Research
Zacks Investment Research upgraded shares of Tivity Health (NASDAQ:TVTY) from a hold rating to a buy rating in a research report released on Thursday morning. The firm currently has $44.00 price objective on the stock.
According to Zacks, “Tivity Health, Inc. provides health management services. The company offers services which include chiropractic services, physical therapy, occupational therapy, speech therapy, acupuncture, massage and complementary and alternative medicine services. Its network comprises SilverSneakers(R), Prime(R) Fitness and WholeHealth Living (TM). Tivity Health, Inc., formerly known as Healthways, Inc., is based in Franklin, Tennessee. “
TVTY has been the topic of several other reports. ValuEngine downgraded Tivity Health from a buy rating to a hold rating in a research report on Monday, November 6th. Chardan Capital restated a neutral rating and issued a $44.00 price objective (up from $40.00) on shares of Tivity Health in a research report on Friday, October 27th. Cantor Fitzgerald restated a buy rating and issued a $45.00 price objective on shares of Tivity Health in a research report on Monday, November 6th. Oppenheimer upped their price objective on Tivity Health from $47.00 to $50.00 and gave the company an outperform rating in a research report on Wednesday, November 1st. Finally, SunTrust Banks restated a buy rating and issued a $46.00 price objective on shares of Tivity Health in a research report on Thursday, October 12th. Three analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Tivity Health currently has a consensus rating of Buy and a consensus target price of $45.25.
Tivity Health (NASDAQ:TVTY) last issued its quarterly earnings data on Thursday, October 26th. The company reported $0.46 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.36 by $0.10. Tivity Health had a return on equity of 30.23% and a net margin of 11.45%. The business had revenue of $137.70 million for the quarter, compared to the consensus estimate of $137.95 million. Tivity Health’s quarterly revenue was up 10.2% compared to the same quarter last year. sell-side analysts anticipate that Tivity Health will post 1.61 EPS for the current fiscal year.
In related news, CAO Glenn Hargreaves sold 5,805 shares of the stock in a transaction dated Thursday, November 2nd. The stock was sold at an average price of $45.15, for a total transaction of $262,095.75. Following the transaction, the chief accounting officer now directly owns 44,448 shares in the company, valued at $2,006,827.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Mary Flipse sold 5,000 shares of the stock in a transaction dated Friday, November 3rd. The stock was sold at an average price of $48.11, for a total value of $240,550.00. Following the transaction, the insider now owns 45,167 shares in the company, valued at $2,172,984.37. The disclosure for this sale can be found here. Insiders have sold 875,892 shares of company stock worth $31,815,642 over the last quarter. 8.42% of the stock is currently owned by company insiders.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Flinton Capital Management LLC lifted its position in Tivity Health by 63.5% during the second quarter. Flinton Capital Management LLC now owns 3,502 shares of the company’s stock worth $139,000 after buying an additional 1,360 shares during the period. Riverhead Capital Management LLC raised its holdings in shares of Tivity Health by 69.7% in the 2nd quarter. Riverhead Capital Management LLC now owns 3,564 shares of the company’s stock worth $142,000 after purchasing an additional 1,464 shares during the period. SG Americas Securities LLC purchased a new position in shares of Tivity Health in the 3rd quarter worth about $210,000. Crossmark Global Holdings Inc. purchased a new position in shares of Tivity Health in the 3rd quarter worth about $279,000. Finally, Piedmont Investment Advisors LLC purchased a new position in shares of Tivity Health in the 2nd quarter worth about $290,000.
TRADEMARK VIOLATION NOTICE: This news story was originally posted by Daily Political and is the sole property of of Daily Political. If you are viewing this news story on another domain, it was illegally stolen and republished in violation of U.S. and international copyright and trademark legislation. The original version of this news story can be accessed at https://www.dailypolitical.com/2018/01/29/tivity-health-tvty-upgraded-at-zacks-investment-research.html.
About Tivity Health
Tivity Health, Inc, formerly Healthways, Inc, is focused targeted population health for those aged 50 and older. The Company offers three programs: SilverSneakers senior fitness, Prime fitness and WholeHealth Living. The SilverSneakers senior fitness program is offered to members of Medicare Advantage, Medicare Supplement, and Group Retiree plans.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.